Zaid Fadul, MD, FS, FAAFP, joins for part 2 to discuss what greater adoption of AI across health care ecosystems might mean for pharmacists, patients, and more.
|Expert Interviews|August 28, 2019
Breaking Down Barriers and Workflow Challenges
Advertisement
Phyllis Houston, Vice President, Program Development and Market Intelligence at AmerisourceBergen, describes the two vital tools Good Neighbor Pharmacy provides to break down the barriers and workflow challenges that allow them to have access to these tools to support their daily function.
Advertisement
Related to this article
For pharmacies competing with CVS and relying on Caremark to serve patients, the prospect of those businesses operating under separate ownership is significant.
Erin Albert of Mark Cuban Cost Plus Drugs explains how the Team Cuban Card offers transparent pricing and fair pay for independent pharmacies.
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
Matthew Crawford, PhD, of the University of Virginia, and Mario Danek of Qnovia explain what pharmacists can do now and what may come next.
The inquiry puts audit practices, including how pharmacies are selected for audit, proportionality, and pharmacy advocacy in focus.
Nolla Derm’s overseeing physician, Zaid Fadul, MD, FS, FAAFP, discusses the revolutionary AI technology that could transform how health care conducts prescribing practices.
As COVID-19 vaccine guidance shifts, new data suggest vaccinated patients face no greater clot or death risk than with other respiratory infections.
Advertisement
Advertisement
Trending on Drug Topics
1
CVS Plans to Split Off Its Retail Pharmacies, Keeping Specialty Operations
2
PBM Audit Practices Under Scrutiny: What the House Inquiry Means for Independent Pharmacies
3
GLP-1s Outperform Metformin in Prediabetes Risk, MACE
4
Team Cuban Card Includes Transparent Pricing for Cash Patients
5